The orphan diseases market is on an upward trajectory, characterized by a significant increase in market volume projected to reach USD 357.8 million by 2035. This anticipated growth, from a baseline of USD 166.93 million in 2023, is underlined by a CAGR of 6.04%. The escalating urgency for innovative treatments targeting rare diseases is motivating pharmaceutical firms to expand their product...